Justia U.S. Federal Circuit Court of Appeals Opinion Summaries

The case involves a breach of contract action brought by socially disadvantaged farmers against the United States Department of Agriculture (USDA) regarding Farm Service Agency (FSA) loans. The plaintiffs, Lester Bonner and Princess Williams, claimed that the USDA breached an express or implied-in-fact contract by failing to provide debt relief after the Inflation Reduction Act repealed a provision of the American Rescue Plan Act (ARPA) that mandated such relief.The United States Court of Federal Claims dismissed the plaintiffs' complaint for failure to state a claim upon which relief could be granted. The court found that the plaintiffs did not plausibly allege the formation of a contract, as they failed to demonstrate mutuality of intent, lack of ambiguity in offer and acceptance, consideration, and a government representative with actual authority to bind the United States.The United States Court of Appeals for the Federal Circuit reviewed the case and affirmed the lower court's decision. The appellate court held that the plaintiffs did not plausibly allege mutuality of intent to contract, which is a threshold condition for contract formation. The court found that the language of ARPA § 1005, which directed the Secretary of Agriculture to provide payments, did not create a contractual obligation. The court also determined that the FSA-2601 form, which informed recipients of their eligibility for payment, did not demonstrate the government's intent to contract. The court concluded that the statutory grant of payment under ARPA was a gratuity and not a contractual right. Consequently, the Court of Federal Claims' dismissal of the complaint was affirmed. View "BOYD v. US " on Justia Law

Marmen Inc., Marmen Énergie Inc., and Marmen Energy Co. (collectively, “Marmen”) appealed the U.S. Court of International Trade’s (CIT) decision that sustained the U.S. Department of Commerce’s (Commerce) final determination of a 4.94% dumping margin for utility-scale wind towers from Canada. Commerce had initiated an antidumping (AD) investigation in July 2019, and in June 2020, issued its final AD determination. Marmen challenged Commerce’s decision on three grounds: the weight-averaging of steel plate costs, the rejection of a USD-to-CAD cost reconciliation, and the use of the average-to-transaction (A-to-T) methodology based on Cohen’s d test.The CIT affirmed Commerce’s weight-averaging of Marmen’s steel plate costs but remanded the case on the other two issues. Commerce again rejected the USD-to-CAD cost reconciliation on remand, arguing it would double count an exchange-rate adjustment. Commerce also maintained its use of Cohen’s d test, despite concerns raised by the Federal Circuit in Stupp Corp. v. United States. The CIT sustained Commerce’s determination on both issues, leading to Marmen’s appeal.The United States Court of Appeals for the Federal Circuit reviewed the case. The court found that Commerce’s rejection of the USD-to-CAD cost reconciliation was not supported by substantial evidence, as the proposed adjustment did not duplicate other adjustments and was reliable. The court also concluded that Commerce’s use of Cohen’s d test was unreasonable because the data did not meet the necessary assumptions of normal distribution, equal variability, and sufficient size. The court vacated Commerce’s calculated dumping margin and remanded for further proceedings consistent with its opinion. View "MARMEN INC. v. US " on Justia Law

Dongkuk S&C Co., Ltd., a Korean producer of utility scale wind towers, challenged the United States Department of Commerce's final determination that its wind towers were being sold in the United States at less than fair value, resulting in an antidumping duty order. Commerce's investigation covered sales from July 1, 2018, to June 30, 2019, and found that Dongkuk's sales were below normal value, leading to the imposition of antidumping duties.The Court of International Trade (CIT) initially remanded Commerce's decision to adjust Dongkuk's steel plate costs, questioning the analytical support for Commerce's determination. Commerce provided additional analysis on remand, demonstrating that the cost variations were due to the timing of steel plate purchases rather than the physical characteristics of the wind towers. The CIT subsequently sustained Commerce's remand redetermination and upheld the choice of surrogate financial data for calculating constructed value profit and selling expenses.The United States Court of Appeals for the Federal Circuit reviewed the case and affirmed the CIT's decision. The court held that Commerce's determination to adjust Dongkuk's steel plate costs was supported by substantial evidence, as the cost variations were unrelated to the physical characteristics of the wind towers. Additionally, the court upheld Commerce's use of SeAH Steel Holdings Corporation's consolidated financial statement as a reasonable source of surrogate data for calculating constructed value profit and selling expenses, despite Dongkuk's preference for SeAH Steel Corporation's standalone financial data. The court found that Commerce's decision was reasonable and supported by substantial evidence. View "DONGKUK S&C CO., LTD. v. US" on Justia Law

Target Corporation (Target) imported goods subject to an antidumping duty order and paid duties at a lower rate than specified in a final judgment. The United States Customs and Border Protection (Customs) later realized the error but did not correct it within the statutory 90-day window. The United States Court of International Trade (CIT) ordered Customs to reliquidate the entries at the correct rate, despite the statutory finality provisions.In the lower court, the CIT granted the government's motion to dismiss Target's challenge to the reliquidation, relying on its previous decision in Home Products International, Inc. v. United States. The CIT held that it had the authority to enforce its judgments and that the principle of finality in 19 U.S.C. § 1514 did not bar correcting Customs' errors in liquidating entries covered by a trade action.The United States Court of Appeals for the Federal Circuit reviewed the case and reversed the CIT's decision. The Federal Circuit held that the case was governed by its precedent in Cemex, S.A. v. United States, which established that Customs' liquidation decisions, even if erroneous, are final and conclusive under 19 U.S.C. § 1514(a) unless specific statutory exceptions apply. The court rejected the CIT's interpretation that it could use its equitable powers to override the statutory finality provisions. The Federal Circuit emphasized that Congress has carefully crafted a statutory scheme for finality and that any remedy for the harshness of the statute should come from Congress, not the courts. View "TARGET CORPORATION v. US " on Justia Law

Recentive Analytics, Inc. owns four patents related to the use of machine learning for generating network maps and schedules for television broadcasts and live events. The patents are divided into two groups: the "Machine Learning Training" patents and the "Network Map" patents. The Machine Learning Training patents focus on optimizing event schedules using machine learning models, while the Network Map patents focus on creating network maps for broadcasters using similar techniques. Recentive sued Fox Corp. and its affiliates for patent infringement.The United States District Court for the District of Delaware dismissed the case, ruling that the patents were directed to ineligible subject matter under 35 U.S.C. § 101. The court found that the patents were focused on the abstract idea of using generic machine learning techniques in a specific environment without any inventive concept. Recentive acknowledged that the patents did not claim the machine learning techniques themselves but rather their application to event scheduling and network map creation.The United States Court of Appeals for the Federal Circuit reviewed the case and affirmed the district court's decision. The Federal Circuit held that the patents were directed to abstract ideas and did not contain an inventive concept that would transform them into patent-eligible applications. The court noted that the use of generic machine learning technology in a new environment, such as event scheduling or network map creation, does not make the patents eligible. The court also rejected Recentive's argument that the increased speed and efficiency of the methods rendered them patent-eligible. The Federal Circuit concluded that the district court did not err in denying leave to amend, as any amendment would have been futile. View "RECENTIVE ANALYTICS, INC. v. FOX CORP. " on Justia Law

Sage Products, LLC (“Sage”) challenged the final written decisions of the Patent Trial and Appeal Board (“Board”) which found all challenged claims of two of its patents unpatentable. The patents in question, U.S. Patent Nos. 10,398,642 and 10,688,067, relate to a sterilized chlorhexidine product in a package, such as an applicator filled with an antiseptic composition for disinfecting skin. The key claims at issue include claims 1-3, 5-8, 10-18, and 20 of the ’642 patent and claims 1-3, 5-8, and 10-19 of the ’067 patent.The Board relied on four key pieces of prior art in finding Sage’s claims unpatentable: the ChloraPrep Public Assessment Report (“PAR”), British Standard EN 556-1 (“BS EN-556-1”), U.S. Patent Application Publication 2015/0190535 (“Degala”), and U.S. Patent Publication No. 2014/0371695 (“Chiang”). The Board found that a skilled artisan would understand the PAR’s references to “sterile” to mean “sterilized” as used in the Sage patents. The Board determined that the PAR disclosed all elements of the challenged claims, including the sterilized chlorhexidine gluconate composition and the sterilized applicator.The United States Court of Appeals for the Federal Circuit reviewed the Board’s findings and affirmed the judgment. The court held that substantial evidence supported the Board’s findings that a skilled artisan would understand the PAR to describe a “sterilized” composition and product. The court also found that the Board correctly determined that the PAR disclosed the limitations of the dependent claims, including the “sterilized colorant” and the sterility assurance level (SAL) of 10-3 to 10-9. The court rejected Sage’s procedural arguments, finding no abuse of discretion in the Board’s reliance on expert testimony and other evidence to interpret the PAR. The court concluded that the Board’s decision was supported by substantial evidence and affirmed the Board’s finding of unpatentability. View "SAGE PRODUCTS, LLC v. STEWART " on Justia Law

Heritage Alliance offers voter guides under the names “iVoterGuide” and “iVoterGuide.com.” In January 2019, the American Policy Roundtable (APR) filed for registration of the marks “iVoters” and “iVoters.com.” Heritage opposed APR’s registration, claiming that APR’s marks would likely be confused with Heritage’s marks, for which Heritage claimed priority of use. The Trademark Trial and Appeal Board (Board) of the United States Patent and Trademark Office (PTO) found that Heritage’s prior-use marks were not protectable because they were highly descriptive and had not acquired distinctiveness, and dismissed the opposition.The Board determined that Heritage had begun using its iVoterGuide marks well before APR’s first use date. However, the Board found that APR effectively conceded likelihood of confusion. Despite this, the Board ruled that Heritage’s prior-use marks were not protectable as trademarks because they were highly descriptive and had not acquired distinctiveness. The Board found that the marks were highly descriptive as they clearly described the service offered, and that Heritage’s evidence of acquired distinctiveness was insufficient.The United States Court of Appeals for the Federal Circuit reviewed the Board’s decision. The court affirmed the Board’s findings that the iVoterGuide marks were highly descriptive and had not acquired distinctiveness. The court found that the Board’s determination was supported by substantial evidence, including the descriptive nature of the marks and the limited additional evidence of acquired distinctiveness. The court concluded that the Board’s decision to dismiss the opposition was correct and affirmed the dismissal. View "HERITAGE ALLIANCE v. AMERICAN POLICY ROUNDTABLE " on Justia Law

Azurity Pharmaceuticals, Inc. filed a lawsuit against Alkem Laboratories Ltd. under the Hatch-Waxman Act, alleging infringement of claims 5, 7, 8, and 9 of U.S. Patent No. 10,959,948. The patent pertains to non-sterile drinkable liquid formulations containing the antibiotic vancomycin. Alkem had submitted an Abbreviated New Drug Application (ANDA) for a product that Azurity claimed infringed on their patent.The United States District Court for the District of Delaware conducted a two-day bench trial and concluded that Alkem’s ANDA did not infringe any of the asserted claims of the ’948 patent. The court found that Azurity had disclaimed any presence of propylene glycol in the prosecution history of the ’948 patent. Since Alkem’s ANDA product contained propylene glycol, the court ruled in favor of Alkem. Azurity argued that a stipulation made during discovery should preclude Alkem’s disclaimer argument, but the district court found this interpretation unpersuasive.The United States Court of Appeals for the Federal Circuit reviewed the case and affirmed the district court’s decision. The Federal Circuit agreed that Azurity had clearly and unmistakably disclaimed propylene glycol during the prosecution of the ’948 patent. The court also found that the stipulation regarding suitable flavoring agents did not preclude the application of the disclaimer. Consequently, the presence of propylene glycol in Alkem’s ANDA product established non-infringement of the ’948 patent claims. The Federal Circuit affirmed the district court’s judgment, holding that Alkem’s ANDA product did not infringe the asserted claims of the ’948 patent. View "AZURITY PHARMACEUTICALS, INC. v. ALKEM LABORATORIES LTD. " on Justia Law

Joshua Smith was substituted in his deceased veteran father’s appeal to the Board of Veterans’ Appeals. The Board denied Mr. Smith’s request for an earlier effective date for benefits for service-connected injuries based on allegedly newly associated service department records. The U.S. Court of Appeals for Veterans Claims affirmed the Board's decision.The Department of Veterans’ Affairs (VA) regional office initially granted service connection for PTSD effective from the date of the 2010 request to reopen the claim. Mr. Smith, Sr. appealed for an earlier effective date. The Board remanded the case to obtain complete records, and the regional office found a PTSD diagnosis from 2007 but did not grant an earlier effective date. After Mr. Smith, Sr. died, the Board dismissed the appeal as moot. Joshua Smith was substituted as the claimant, and the Board granted an earlier effective date based on the 2007 diagnosis but limited Mr. Smith’s eligibility to accrued benefits necessary for last sickness or burial expenses. The regional office calculated the total accrued benefits and deferred a decision on payment pending evidence of expenses.The United States Court of Appeals for the Federal Circuit reviewed the case. The court determined that Mr. Smith’s appeal was moot because, as a substituted party, he was only entitled to reimbursement for last sickness and burial expenses, which amounted to $1,143. Since the accrued benefits already exceeded this amount, any decision granting an earlier effective date would not affect the outcome for Mr. Smith. The court dismissed the appeal. View "SMITH v. COLLINS " on Justia Law

In 2008, the plaintiff, ams-OSRAM USA Inc. (formerly Texas Advanced Optoelectronic Solutions, Inc. or TAOS), sued Renesas Electronics America, Inc. (formerly Intersil Corporation) in the Eastern District of Texas. TAOS alleged patent infringement and state-law claims of trade secret misappropriation and breach of a confidentiality agreement related to ambient-light sensors. The patent claim is no longer at issue. TAOS claimed that Intersil used confidential information disclosed during merger discussions to develop competing products.The district court entered a judgment in 2015 based on a jury verdict, awarding TAOS damages for trade secret misappropriation but not for breach of contract, deeming the latter duplicative. In 2018, the Federal Circuit affirmed Intersil’s liability for trade secret misappropriation on a narrower basis, vacated the monetary award, and remanded for further proceedings. The court also vacated the judgment denying contract damages as duplicative.On remand, the district court held additional proceedings, including a new jury trial. The court awarded TAOS $8,546,000 in disgorged profits for trade secret misappropriation, $17,092,000 in exemplary damages, and reasonable royalties for breach of contract totaling $6,637,693. The court also awarded prejudgment interest and attorneys’ fees. Both parties appealed.The United States Court of Appeals for the Federal Circuit affirmed the district court’s findings on the trade secret and contract claims, including the disgorgement and exemplary damages awards. However, the court reversed the finding that the trade secret became properly accessible in January 2006, determining the correct date to be February 28, 2005. The court affirmed the 26-month head-start period and the inclusion of profits from sales to Apple for the iPod Touch in the disgorgement award. The court vacated the prejudgment interest awards and remanded for further consideration of the appropriate accrual dates for interest on sales occurring after the complaint was filed. View "AMS-OSRAM USA INC. v. RENESAS ELECTRONICS AMERICA, INC. " on Justia Law